Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific Advisory Board Biotech Investing
PENELOPE-B Trial of IBRANCE® in Early Breast Cancer Did Not Meet Primary Endpoint Pharmaceutical Investing
Final Results of National Institute of Allergy and Infectious Diseases' ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® for the Treatment of COVID-19 Biotech Investing
Avricore Health's HealthTab Achieves Critical Milestones in Connecting New Testing Device Medical Device Investing
Salix To Present Clinical Data At United European Gastroenterology Week Virtual 2020 Medical Device Investing
Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate Medical Device Investing
Bausch Health Companies Inc. Provides Preliminary Update On Third-Quarter 2020 Financial Results And Business Recovery Medical Device Investing
Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir in Combination With Doravirine in Adults With HIV-1 Infection Pharmaceutical Investing
Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency Pharmaceutical Investing
Gilead Sciences Signs Joint Procurement Agreement With the European Commission for Veklury® Biotech Investing
Abbott Releases ID NOW COVID-19 Interim Clinical Study Results from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health Medical Device Investing
Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business Biotech Investing
